Cancer in adolescents and young adults (15–29 years): A population-based study in the Netherlands 1989–2009

References

• Bleyer A, O’Leary M, Barr R, Ries LAG. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER Incidence and survival 1975–2000. Bethesda, MD: National Cancer Institute, NIKH Pub. No. 06-5767; 2006.
   Google Scholar
• Croucher C, Whelan JS, Moller H, Davies EA. Trends in the incidence and survival of cancer in teenagers and young adults: Regional analysis for South East England 1960–2002. Clin Oncol (R Coll Radiol) 2009;21: 417–24.
   PubMed Web of Science ®Google Scholar
• van der Horst M, Winther JF, Olsen JH. Cancer incidence in the age range 0–34 years: Historical and actual status in Denmark. Int J Cancer 2006;118:2816–26.
   PubMed Web of Science ®Google Scholar
• Stiller CA, Desandes E, Danon SE, Izarzugaza I, Ratiu A, Vassileva-Valerianova Z, . Cancer incidence and survival in European adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2006–18.
   PubMed Web of Science ®Google Scholar
• Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010;36:277–85.
   PubMed Web of Science ®Google Scholar
• Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, . Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 2009;45:992–1005.
   PubMed Web of Science ®Google Scholar
• van Gaal JC, Bastiaannet E, Schaapveld M, Otter R, Kluin-Nelemans JC, de Bont ES, . Cancer in adolescents and young adults in north Netherlands (1989–2003): Increased incidence, stable survival and high incidence of second primary tumours. Ann Oncol 2009;20:365–73.
   PubMed Web of Science ®Google Scholar
• Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ. Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer 2002;87:1267–74.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• IARC. International rules for multiple primary cancer ICD-O, 3rd edition. Internal report no. 2004/02. Lyon: IARC; 2004.
   Google Scholar
• Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 2010;19:1151–9.
   PubMed Web of Science ®Google Scholar
• Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: Mechanistic insights and potential new downstream effects. Fertil Steril 2008;89(2 Suppl):e33–8.
   PubMedGoogle Scholar
• Holterhues C, Vries E, Louwman MW, Koljenovic S, Nijsten T. Incidence and trends of cutaneous malignancies in the Netherlands, 1989–2005. J Invest Dermatol 2010; 130:1807–12.
   PubMed Web of Science ®Google Scholar
• Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: A midsummer night's dream? Br J Dermatol 2009;161:630–4.
   PubMed Web of Science ®Google Scholar
• Cust AE, Armstrong BK, Goumas C, Jenkins MA, Schmid H, Hopper JL, . Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011;128:2425–35.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Tereanu C, De AR, Capocaccia R, Visser O, . Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project. Blood 2010;116:3724–34.
   PubMed Web of Science ®Google Scholar
• Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol 2009;36:237–49.
   PubMed Web of Science ®Google Scholar
• Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975–1999. Cancer 2008;113:2575–96.
   PubMed Web of Science ®Google Scholar
• Fern LA, Whelan JS. Recruitment of adolescents and young adults to cancer clinical trials – international comparisons, barriers, and implications. Semin Oncol 2010;37:e1–8.
   Google Scholar
• Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 2008;50(5 Suppl):1101–4.
   PubMed Web of Science ®Google Scholar
• Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008;8:288–98.
   PubMed Web of Science ®Google Scholar
• Dang-Tan T, Trottier H, Mery LS, Morrison HI, Barr RD, Greenberg ML, . Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008;51:468–74.
   PubMed Web of Science ®Google Scholar
• Eden T. Keynote comment: Challenges of teenage and young-adult oncology. Lancet Oncol 2006;7:612–3.
   PubMed Web of Science ®Google Scholar
• de Bont JM, Holt B, Dekker AW, van der Does-van den Berg, Sonneveld P, Pieters R. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs. adult protocols in the Netherlands. Leukemia 2004;18:2032–5.
   PubMed Web of Science ®Google Scholar
• Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: Relative survival vs. cancer-specific survival. Int J Epidemiol 2010;39:598–610.
   PubMed Web of Science ®Google Scholar
• Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, . Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011;305:2311–9.
   PubMed Web of Science ®Google Scholar
• Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, . Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2010;102:1083–95.
   PubMedGoogle Scholar